Performance Governance in Pharmaceutical Organizations: A Strategic Framework for Quality, Regulatory Compliance, and Value-Based Healthcare Delivery

Pharmaceutical organizations operate under a multidimensional definition of performance. Financial results, operational efficiency, product quality, regulatory compliance, and healthcare value are all important, yet they are frequently managed through separate functions and performance systems. This fragmentation can obscure the relationships among commercial decisions, quality outcomes, regulatory obligations, and patient-relevant value. This article develops performance governance as an integrated management approach for aligning these dimensions within a common decision architecture. The proposed framework is organized around four interdependent pillars: Quality Integrity, Regulatory Integrity, Organizational Accountability, and Healthcare Value. Quality Integrity addresses the capacity to maintain product and process reliability throughout the pharmaceutical lifecycle. Regulatory Integrity extends formal compliance toward consistent, evidence-based and transparent organizational decision-making. Organizational Accountability establishes clear decision rights, escalation mechanisms, management oversight, and responsibility for outcomes across functional and organizational boundaries. Healthcare Value connects pharmaceutical performance with the outcomes and resources relevant to patients and healthcare systems. These dimensions are consistent with lifecycle-oriented pharmaceutical quality principles, which emphasize management responsibility, process and product monitoring, corrective and preventive action, change management, and continual improvement (International Council for Harmonisation [ICH], 2008). The framework also recognizes that healthcare performance increasingly requires attention to outcomes in relation to the resources used to achieve them (Porter, 2010). Performance governance therefore extends conventional KPI-based assessment by examining how results are produced, challenged, sustained, and translated into organizational and healthcare value. The article argues that durable pharmaceutical performance depends on the integration of quality, regulatory discipline, accountability, and healthcare value into strategic and operational decision-making.

Authors

Publication Details

Journal
International Journal of Research Publications
Published
2026-11-17
DOI
https://doi.org/10.47119/ijrp10020911120269869
Primary Topic
Healthcare Quality and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Performance Governance in Pharmaceutical Organizations: A Strategic Framework for Quality, Regulatory Compliance, and Value-Based Healthcare Delivery

Maysa Meredova
2 links
International Journal of Research Publications
Healthcare Quality and Management
article

Performance Governance in Pharmaceutical Organizations: A Strategic Framework for Quality, Regulatory Compliance, and Value-Based Healthcare Delivery

Maysa Meredova
article en

Abstract

Pharmaceutical organizations operate under a multidimensional definition of performance. Financial results, operational efficiency, product quality, regulatory compliance, and healthcare value are all important, yet they are frequently managed through separate functions and performance systems. This fragmentation can obscure the relationships among commercial decisions, quality outcomes, regulatory obligations, and patient-relevant value. This article develops performance governance as an integrated management approach for aligning these dimensions within a common decision architecture. The proposed framework is organized around four interdependent pillars: Quality Integrity, Regulatory Integrity, Organizational Accountability, and Healthcare Value. Quality Integrity addresses the capacity to maintain product and process reliability throughout the pharmaceutical lifecycle. Regulatory Integrity extends formal compliance toward consistent, evidence-based and transparent organizational decision-making. Organizational Accountability establishes clear decision rights, escalation mechanisms, management oversight, and responsibility for outcomes across functional and organizational boundaries. Healthcare Value connects pharmaceutical performance with the outcomes and resources relevant to patients and healthcare systems. These dimensions are consistent with lifecycle-oriented pharmaceutical quality principles, which emphasize management responsibility, process and product monitoring, corrective and preventive action, change management, and continual improvement (International Council for Harmonisation [ICH], 2008). The framework also recognizes that healthcare performance increasingly requires attention to outcomes in relation to the resources used to achieve them (Porter, 2010). Performance governance therefore extends conventional KPI-based assessment by examining how results are produced, challenged, sustained, and translated into organizational and healthcare value. The article argues that durable pharmaceutical performance depends on the integration of quality, regulatory discipline, accountability, and healthcare value into strategic and operational decision-making.

International Journal of Research PublicationsVol. 209(1)
Healthcare Quality and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon